Department of Health and Social Care
Department of Health and Social Care (DHSC) is a department of the Government of the United Kingdom responsible for government policy on health and adult social care matters in England, along with a few elements of the same matters which are not otherwise devolved to the devolved governments of Scotland, Wales, and Northern Ireland. It oversees the English National Health Service (NHS). The DHSC's work includes public health, social care, and health education.
History[edit]
The Department of Health was created in 1988 through the merger of the Department of Health and Social Security (DHSS) with elements of the Ministry of Health. It was renamed the Department of Health and Social Care in January 2018 to reflect its broader responsibility for adult social care. The department's remit has evolved over time in response to the changing needs of the public and the challenges facing the health and social care systems.
Responsibilities[edit]
The DHSC is responsible for setting overall policy on health and social care matters in England and for leading and funding the NHS. Its responsibilities include:
- Setting the strategic framework for the NHS and social care workforce
- Research and development in health and social care
- Public health, including health protection and health improvement
- Regulation and safety of medicines and medical devices
- Management of major health and social care crises
The department works with a number of Executive agencies and public bodies including Public Health England (PHE), the Care Quality Commission (CQC), and the Medicines and Healthcare products Regulatory Agency (MHRA).
Structure[edit]
The DHSC is headed by the Secretary of State for Health and Social Care, who is a Cabinet member. Below the Secretary of State, there are a number of Ministers responsible for various aspects of health and social care policy. The department itself is divided into directorates that handle specific areas of health and social care policy, such as the NHS, public health, and social care.
Funding[edit]
The DHSC is funded through the UK government's budgetary process. It allocates resources to the NHS, public health, and social care services based on assessments of need and strategic priorities. The department's budget is subject to annual review and approval by Parliament.
Challenges[edit]
The DHSC faces numerous challenges, including the rising demand for health and social care services, the aging population, and the need to integrate health and social care services more effectively. Additionally, the department must address public health issues such as obesity, smoking, and mental health, and manage the implications of technological advancements in healthcare.
Criticism and Controversy[edit]
The DHSC has faced criticism for its handling of various health and social care issues, including hospital waiting times, funding for mental health services, and the response to the COVID-19 pandemic. Critics argue that the department needs to do more to address inequalities in health and social care provision.
See Also[edit]
- National Health Service (England)
- Public Health England
- Care Quality Commission
- Medicines and Healthcare products Regulatory Agency
-
39 Victoria Street lit up in Ukrainian flag to stand with Ukraine
-
Official portrait of Wes Streeting
-
Official portrait of Stephen Kinnock MP
-
Official portrait of Karin Smyth MP
-
Official portrait of Baroness Merron
-
Official portrait of Andrew Gwynne MP
-
Quarry House, Leeds
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian